OBESE FEMALE SHHF/Mcc-fa^cp RATS RESIST ANTIHYPERTENSIVE EFFECTS OF RENIN-ANGIOTENSIN SYSTEM INHIBITION

REFERENCES

• Weir M. R. Impact of age, race and obesity on hypertensive mechanisms and therapy. Am J Med 1991 1991; 90: 3S–14S, (suppl5A)
   Google Scholar
• Klassen G. A., Yeung P. F.K., Barclay K. D., Hung O. R., Pollak T., Buckley S. J. Gender differences in exercise and recovery blood pressure responses in normal volunteers given diltiazem. J Clin Pharmacol 1995; 35: 1144–1149
   PubMed Web of Science ®Google Scholar
• Kloner R. A., Sowers J. R., DiBona G. F., Gaffney M., Wein M. Sex-and age-related antihypertensive effects of amlodipine. Am J Cardiol 1996; 77: 713–722
   PubMed Web of Science ®Google Scholar
• Walle T., Walle K., Cowart T. D., Conradi E. C. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther 1989; 46: 257–263
   PubMed Web of Science ®Google Scholar
• Reisin E., Weir M. R., Falkner B., Hutchinson H. G., Anzalone D. A., Tuck M. L. (TROPHY study group). Lisinopril versus hydrochlorothiazide in obese hypertensive patients. Hypertension 1997; 30(part 1)140–145
   PubMed Web of Science ®Google Scholar
• Cazaubon C., Gougat J., Bousquet F., Guiraudou P., Gayraud R., Lacour C., Roccon A., Galindo G., Barthelmeny G., Gautret B., Bernhart C., Perreaut P., Breliere J. C., Le Fur G., Nisato D. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist. J Pharmacol Exp Ther 1993; 265: 826–834
   PubMed Web of Science ®Google Scholar
• McCune S. A., Jenkins J. E., Stills H. F., Park S., Radin M. J., Jurin R. R., Hamlin R. E. Renal and heart function in the SHHF/Mcc^-cp rat, E Shafrir. Frontiers in diabetes research. Lessons from animal diabetes III, Smith Gordon, London 1990; 397–401
   Google Scholar
• Radin M. J., Jenkins J. E., McCune S. A., Jurin R. R., Hamlin R. L. Effects of enalapril and clonidine on glomerular structure, function, and atrial natriuretic peptide receptors in SHHF/Mcc-cp rats. J Cardiovasc Pharmacol 1992; 19: 464–472
   PubMed Web of Science ®Google Scholar
• Radin M. J., Chu Y. Y., Hoepf T. M., McCune S. A. Treatment of obese female and male SHHF rats with antihypertensive drugs, nifedipine and enalapril: effects on body weight, fat distribution, insulin resistance, and systolic pressure. Obes Res 1993; 1: 433–442
   PubMedGoogle Scholar
• Carraway J. W., Park S., McCune S. A., Holycross B. A., Radin M. J. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-facp rats. J Cardiovasc Pharmacol 1999; 33: 451–460
   PubMed Web of Science ®Google Scholar
• Holycross B. J., McCune S. A., Hoepf T., Carraway J., Radin M. J. Role of obesity and gender in regulating responsiveness to irbesartan, captopril, and angiotensin II in a hypertensive rat model. Am J Hypertens 1996; 9: 146A
   Google Scholar
• Sharkey L. C., Holycross B. J., Park S., McCune S. A., Hoversland R., Radin M. J. Effect of ovarietomy in heart failure prone SHHF-Mcc-facp rats. Am J Physiol 1998; 275: R1968–1976
   Google Scholar
• Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59: 365–372
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54
   PubMed Web of Science ®Google Scholar
• Crofton J. T., Ota M., Share L. Role of vasopressin, the renin-angiotensin system and sex in Dahl salt-sensitive hypertension. J Hypertens 1993; 11: 1031–1038
   PubMed Web of Science ®Google Scholar
• Nigro D., Fortes Z. B., Scivoletto R., Barbeiro H. V., Carvalho M. H. Sex-related differences in the response to angiotensin-converting enzyme inhibitor. Endothelium 1997; 5: 63–71
   PubMed Web of Science ®Google Scholar
• Nunez E., Hosoya K., Susic D., Frohlich E. D. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR. Hypertension 1997; 29(part 2)519–524
   PubMedGoogle Scholar
• Rodrigo E., Maeso R., Muñoz-Garc'a R., Navarro-Cid J., Ruilope L. M., Cachofeiro V., Lahero V. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril. J Hypertens 1997; 15: 613–618
   PubMed Web of Science ®Google Scholar
• Sacerdote A., Cosenzi A., Bocin E., Molino R., Seculin P., Plazzotta N., Luxich E., Bellini G. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats. J Hypertens 1995; 13: 1670–1673
   PubMed Web of Science ®Google Scholar
• Ziai F., Ots M., Provoost A. P., Troy J. L., Rennke H. G., Brenner B. M., Mackenzie H. S. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure. Kidney Int 1996; 50: S132–136, (Suppl 57)
   Google Scholar
• Geenen D. L., Malhotra A., Buttrick P. M. Angiotensin receptor 1 blockade does not prevent physiological cardiac hypertrophy in the adult rat. J Appl Physiol 1996; 81: 816–821
   PubMed Web of Science ®Google Scholar
• Goodfriend T. L., Elliot M. E., Catt K. J. Angiotensin receptors and their antagonists. N Eng J Med 1996; 334: 1649–1654
   PubMed Web of Science ®Google Scholar
• Barton M., Carmona R., Morawietz H., d'Uscio L. V., Goettsch W., Hillen H., Haudenschild C. C., Krieger J. E., Münter K., Lattmann T., Lüscher T. F., Shaw S. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension 2000; 35rt 2: 329–336
   Google Scholar
• Scholz H., Krämer B. K., Hamann M., Götz K-H., Kurtz A. Effects of endothelins on renin secretion from rat kidneys. Acta Physiol Scand 1995; 155: 173–182
   PubMedGoogle Scholar
• Paul M., Ganten D. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system. J Cardiovasc Pharmacol 1992; 19(Suppl5)S510–S518
   Google Scholar
• Ito H., Hirata Y., Adachi S., Tanaka M., Tsujino M., Koike A., Nogami A., Murumo F., Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993; 92: 398–403
   PubMed Web of Science ®Google Scholar